ArticleBMC oral health2026
Assessment of Anti-M3R antibody in patients with oral lichen planus complaining of xerostomia: a preliminary study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveOral lichen planus (OLP) is a chronic inflammatory disorder mediated by cellular immunity. Xerostomia is not a typical feature but has been reported by a subset of patients and may reflect underlying salivary gland alterations. The mechanisms contributing to xerostomia in OLP remain unclear. This study evaluated the levels of autoantibodies against the muscarinic M3 receptor (anti-M3R Ab) in the labial minor salivary glands, saliva, and serum of OLP patients with xerostomia and compared them with those of healthy controls.
methodsIn this case-control study, unstimulated whole saliva, serum samples, and labial minor salivary gland biopsies were obtained from 35 patients with OLP and xerostomia and 25 healthy controls. Anti-M3R Ab levels were measured using enzyme-linked immunosorbent assay (ELISA). Statistical analyses included Mann-Whitney U test, Spearman correlation coefficients, and multiple logistic regression.
resultsAnti-M3R Ab levels were significantly reduced in minor salivary gland tissue of OLP patients compared with controls. Lower anti-M3R Ab levels in minor salivary glands were statistically associated with higher xerostomia scores and lower unstimulated salivary flow rates. Correlation analyses showed a significant inverse relationship between glandular anti-M3R Ab levels and xerostomia severity.
conclusionsThe reduction of anti-M3R Ab within minor salivary gland tissue may represent a localized immunological alteration contributing to xerostomia in OLP. These findings underscore the importance of localized, rather than systemic, immune mechanisms in the salivary gland dysfunction observed in OLP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.